연구동향 분석

Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia

Minggen Yang Zhenqiang Xu Zhiming Zhuang 2021년

논문상세정보
인용/피인용
' Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • MDV3100
  • MiR-21-3p
  • androgen receptor antagonist
  • benign prostatic hyperplasia
  • ki-67
  • nf-κb pathway
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
91 0

0.0%

' Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia' 의 참고문헌

  • Urine miR-21-5p as a potential biomarker for predicting effectiveness of tadalafil in benign prostatic hyperplasia
    Tanaka T [2018]
  • The nuclear factor kappa B signaling pathway : integrating metabolism with inflammation
    Tornatore L [2012]
  • The functional analysis of MicroRNAs involved in NF-kappaB signaling
    Yang Y [2016]
  • Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms
    Li J [2018]
  • Testosterone and benign prostatic hyperplasia
    Rastrelli G [2019]
  • Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia
    Popovics P [2020]
  • Prognostic value of novel liquid biomarkers in patients with metastatic castration-resistant prostate cancer treated with enzalutamide : a prospective observational study
    Benoist GE [2020]
  • NFkappaB signaling promotes castration-resistant prostate cancer initiation and progression
  • NF-kappaB signaling in inflammation
    Liu T [2017]
  • MicroRNAs control transcription factor NF-kB(p65)expression in human ovarian cells
    Sirotkin AV [2015]
  • MicroRNA-21 inhibits lipopolysaccharide-induced acute lung injury by targeting nuclear factor-kappaB
    Zhu WD [2018]
  • MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer
    Wu J [2018]
  • MicroRNA expression profiles in benign prostatic hyperplasia
    Zhang N [2018]
  • Management of benign prostatic hyperplasia
    Kim EH [2016]
  • Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review
    Alcaraz A [2009]
  • Inflammation and NF-kappaB signaling in prostate cancer : mechanisms and clinical implications
    Staal J [2018]
  • IL-6 inhibits the targeted modulation of PDCD4 by miR-21 in prostate cancer
    Dong B [2015]
  • Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
  • Effects of doxazosin on alpha 1-adrenergic receptors in prostates with benign prostatic hyperplasia
    Lee HN [2013]
  • Effect of miR-21/TLR4/NFkappaB pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion
    Pan YQ [2018]
  • Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia : evaluation of potential diagnostic and prognostic role
    Cochetti G [2016]
  • Detecting predictive androgen receptor modifications in circulating prostate cancer cells
  • Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancer
    Li H [2013]
  • CBX7regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-kappaB-miR-21 pathways
    Ni SJ [2018]
  • Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes
    Lakhter AJ [2018]
  • Benign prostatic hyperplasia treatment using plasmonic nanoparticles irradiated by laser in a rat model
  • Benign prostatic hyperplasia and urinary symptoms : Evaluation and treatment
    Mobley, D. [2015]
  • Benign prostatic hyperplasia
  • Association of microRNA-21expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy
    Guan Y [2016]
  • Androgen receptor pathway-independent prostate cancer is sustained through fgf signaling
    Bluemn EG [2017]
  • Androgen receptor antagonists in castration-resistant prostate cancer
    Rathkopf D [2013]
  • Abiraterone and MDV3100 inhibits the proliferation and promotes the apoptosis of prostate cancer cells through mitophagy
    Han J [2019]